title: Phosphodiesterase 10A inhibitors as a novel therapeutic approach for schizophrenia.
abstract: Phosphodiesterase 10A (PDE10A) is a recently identified member of the cyclic nucleotide phosphodiesterase family. PDE10A is notable in that it has a relatively restricted distribution: PDE10A mRNA and protein are expressed primarily in the dopaminoreceptive medium spiny neurons of the striatum. Potent and selective PDE10A inhibitors have recently been described in the scientific literature and their in vivo effects suggest the potential uses of PDE10A inhibitors in CNS disorders, particularly schizophrenia. This article provides a brief overview of the presently available scientific literature as well as recent meeting presentations.
authors.affiliation: CNS Discovery, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA.
authors.forename: Judith A
authors.initials: JA
authors.lastname: Siuciak
authors.forename: Christine A
authors.initials: CA
authors.lastname: Strick